Interpace Diagnostics Group (NASDAQ: IDXG) and Cintas Corporation (NASDAQ:CTAS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitabiliy, earnings and valuation.

Volatility and Risk

Interpace Diagnostics Group has a beta of 1.8, meaning that its stock price is 80% more volatile than the S&P 500. Comparatively, Cintas Corporation has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500.

Earnings & Valuation

This table compares Interpace Diagnostics Group and Cintas Corporation’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Interpace Diagnostics Group $13.52 million 0.56 -$10.02 million N/A N/A
Cintas Corporation $5.14 billion 2.59 $997.25 million $4.82 26.23

Cintas Corporation has higher revenue and earnings than Interpace Diagnostics Group.

Profitability

This table compares Interpace Diagnostics Group and Cintas Corporation’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Interpace Diagnostics Group -8.45% -28.77% -5.44%
Cintas Corporation 10.25% 24.32% 11.66%

Analyst Ratings

This is a summary of recent ratings and target prices for Interpace Diagnostics Group and Cintas Corporation, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Interpace Diagnostics Group 0 0 0 0 N/A
Cintas Corporation 1 8 4 0 2.23

Cintas Corporation has a consensus price target of $128.20, indicating a potential upside of 1.40%. Given Cintas Corporation’s higher probable upside, analysts clearly believe Cintas Corporation is more favorable than Interpace Diagnostics Group.

Dividends

Cintas Corporation pays an annual dividend of $1.33 per share and has a dividend yield of 1.1%. Interpace Diagnostics Group does not pay a dividend. Cintas Corporation pays out 27.6% of its earnings in the form of a dividend. Cintas Corporation has raised its dividend for 34 consecutive years.

Institutional and Insider Ownership

1.7% of Interpace Diagnostics Group shares are owned by institutional investors. Comparatively, 68.6% of Cintas Corporation shares are owned by institutional investors. 2.5% of Interpace Diagnostics Group shares are owned by insiders. Comparatively, 19.1% of Cintas Corporation shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Cintas Corporation beats Interpace Diagnostics Group on 12 of the 14 factors compared between the two stocks.

About Interpace Diagnostics Group

Interpace Diagnostics Group, Inc., formerly PDI, Inc., is focused on developing and commercializing molecular diagnostic tests principally focused on early detection of high potential progressors to cancer and leveraging the latest technology and personalized medicine for patient diagnosis and management. The Company operates through molecular diagnostics segment. It offers molecular tests, such as PancraGen, which is a pancreatic cyst molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment utilizing its PathFinder platform; ThyGenX, which assesses thyroid nodules for risk of malignancy, and ThyraMIR, which assesses thyroid nodules risk of malignancy utilizing a gene expression assay. Through its molecular diagnostics business, the Company provides diagnostic options for detecting genetic and other molecular alterations that are associated with gastrointestinal and endocrine cancers, which are focused on early detection of cancer.

About Cintas Corporation

Cintas Corporation is a provider of corporate identity uniforms through rental and sales programs, as well as a provider of related business services, including entrance mats, restroom cleaning services and supplies, carpet and tile cleaning services, first aid and safety services and fire protection products and services. Its segments include uniform rental and facility services, and first aid and safety services. Its uniform rental and facility service segment offers services, which include rental and servicing of uniforms and other garments, including flame resistant clothing, mats, mops and shop towels, and other ancillary items. Its first aid and safety service segment offers services, which include first aid and safety products and services. Rental processing plants, rental branches, first aid and safety facilities, fire protection facilities, direct sales offices, distribution centers and manufacturing facilities are all utilized by the businesses included in All Other.

Receive News & Ratings for Interpace Diagnostics Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Interpace Diagnostics Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.